Skip to main content
. 2020 Apr 16;15(4):e0231716. doi: 10.1371/journal.pone.0231716

Fig 5. SpartaCas shows high efficacy at on-target loci and low off-target editing in T-cells.

Fig 5

(A) Dose-response of indel fraction at the known off-target locus evolved against during phage-based selection. SpartaCas shows similar reduction in off-target editing to eCas9. (B) Dose-response of indel fraction at the on-target locus PD49. (C) On-target editing efficiency compared between wild-type and high-fidelity variants. SpartaCas maintains higher or similar editing efficiency to eCas9 and substantially higher efficiency than HF4. All experiments were performed in technical triplicates. Bars shown indicate standard error.